| PST | pancreatic suppression test; paroxysmal supraventricular tachycardia; penicillin, streptomycin, and ... |
|---|---|
| TE | echo-time; expiratory time; tennis elbow; test ear; tetanus; tetracycline; threshold energy; thrombo... |
| TTI | tension-time index; time-tension index; timepto-intubation; torque-time interval; transtracheal insu... |
| CER | capital expenditure review; ceramide; conditioned emotional response; control electrical rhythm; cor... |
| CR | calculation rate; calculus removed; calorie-restricted; cardiac rehabilitation; cardiac resuscitatio... |
| early-phase response | Prompt onset of symptoms following an antigenic stimulus. (05 Mar 2000) |
|---|---|
| triple response | <immunology> The vascular changes in the skin in response to mild mechanical injury, an outward spreading zone of reddening flare) followed rapidly by a weal (swelling) at the site of injury. Redness, heat and swelling, three of the cardinal signs of inflammation, are present. (18 Nov 1997) |
| evoked response | An alteration in the electrical activity of a region of the nervous system through which an incoming sensory stimulus is passing; may be somatosensory (SER), auditory (BAER), or visual (VER). See: evoked potential. (05 Mar 2000) |
| evoked response audiometry | A type of electrophysiologic audiometry in which electrical potentials of neural impulses from the cochlear nerve and various levels in the brain in response to acoustic stimulation are used to localise the site of a lesion causing a hearing loss. (05 Mar 2000) |
| unconditioned response | A response, such as salivation, which is a part of the animal or human repertoire. Compare: conditioned response. (05 Mar 2000) |
| flight or fight response | See: emergency theory. (05 Mar 2000) |
| late-phase response | Recurrence of symptoms after an appreciable interval following challenge with an antigen; preceded by an initial early-phase response. (05 Mar 2000) |
| lh response to gnrh | This test measures the level of luteinising hormone in the blood after an injection of gonadotrophin releasing hormone (GNRH), normally produced in the hypothalamus. This will test the ability of the pituitary gland to respond by measuring one of the pituitary glands byproducts, luteinising hormone. This test is used to differentiate hypogonadism (ovary or testes) into primary hypogonadism (problem is with the ovary or testes) or secondary hypogonadism (problem is with the pituitary gland or the hypothalamus). (27 Sep 1997) |
| lymphoproliferative response | <haematology, immunology> A specific immune response that entails rapid T-cell replication. Standard antigens, such as tetanus toxoid, that elicit this response are used in lab tests of immune competence. (13 Nov 1997) |
| activated clotting time | The most common test used for coagulation time in cardiovascular surgery. (05 Mar 2000) |
| activated partial thromboplastin time | The time needed for plasma to form a fibrin clot following the addition of calcium and a phospholipid reagent; used to evaluate the intrinsic clotting system. (05 Mar 2000) |
| A-H conduction time | Forward conduction of the cardiac impulse from atria to ventricles via the A-V node or any bypass tract, represented in the electrocardiogram by the P-R interval. P-H conduction time is from the onset of the P wave to the first high frequency component of the His bundle electrogram (normally 119 ± 38 msec); A-H conduction time is from the onset of the first high frequency component of the atrial electrogram to the first high frequency component of the His bundle electrogram (normally 92 ± 38 msec); P-A conduction time is from the onset of the P wave to the onset of the atrial electrogram (normally 27 ± 18 msec). (05 Mar 2000) |
| association time | Time elasping between a stimulus and the verbalised response to it. (05 Mar 2000) |
| biologic time | The concept that our appreciation of time varies with age and is governed by the neural organization of the individual; it obeys a logarithmic rather than an arithmetic law. (05 Mar 2000) |
| bleeding time | <haematology> A test which measures the time it takes for small blood vessels to close off and bleeding to stop. Abnormal results can be seen in those with congenital or acquired platelet function disorders or thrombocytopenia. (27 Sep 1997) |